Document:

Form of 5-5/8% Senior Notes due May 1, 2017

 Exhibit 4.1 
  

			
	 CUSIP NO. 421915 ED 7
	  	PRINCIPAL AMOUNT
		
	 	  	$250,000,000

  
 HEALTH CARE PROPERTY
INVESTORS, INC. 
  
 5 5/8% SENIOR NOTES DUE MAY 1, 2017 
  
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING SET FORTH IN THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED
IN THE NAME OF A DEPOSITARY OR A NOMINEE OF A DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND,
UNLESS AND UNTIL IT IS EXCHANGED FOR SECURITIES IN DEFINITIVE FORM AS AFORESAID, MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE
DEPOSITARY OR BY THE DEPOSITARY OR ITS NOMINEE TO A SUCCESSOR DEPOSITARY OR ITS NOMINEE. 
  
 UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (“DTC”), 55 WATER STREET, NEW YORK, NEW YORK TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR
PAYMENT, AND SUCH NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO., OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC, ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, SINCE
THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
  
 HEALTH CARE PROPERTY INVESTORS, INC., a Maryland corporation (the “Company,” which term shall include any successor under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE & CO., or
registered assigns, the principal sum of Two Hundred Fifty Million Dollars ($250,000,000) on May 1, 2017, and to pay interest thereon from April 27, 2005, or from the most recent interest payment date on which interest has been paid or duly provided
for, semi-annually in arrears on May 1 and November 1 of each year (or if such date is not a Business Day, on the next Business Day thereafter) (each, an “Interest Payment Date”), commencing November 1, 2005, at the rate of 5 5/8% per annum, until the entire principal amount hereof is paid or duly provided for. The interest so payable, and
punctually paid or duly provided for, on any Interest Payment Date will, as provided in the Indenture, be paid to the Holder in whose name this Note (or one or more predecessor Notes) is registered at the close of business on the Regular Record Date
for such interest, which shall be April 15 or October 15 whether or not a Business Day, as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable
to the Holder on such Regular Record Date, and may either be paid to the Holder in whose name this Note (or one or more predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to
be fixed by the Trustee, notice whereof shall be given to Holders of Notes of this series not less than 10 

 
days prior to such Special Record Date, or may be paid at any time in any other lawful manner not inconsistent with the requirements of any securities
exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, all as more fully provided in the Indenture. Interest will be computed on the basis of a 360-day year of twelve 30-day months. Payments of
principal, premium, if any, and interest in respect of this Note will be made by the Company in immediately available funds. 
  
 Payment of the principal of and interest on this Note shall be payable at the Corporate Trust Office of The Bank of New York, located at 101 Barclay
Street, Floor 8 W, New York, New York 10286 or at such other office or agency of the Company maintained for that purpose in The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that, at the option of the Company, interest may be paid by check mailed to the address of the Person entitled thereto as such address shall appear on the Security Register or by transfer to an
account maintained by the payee with a bank located in the United States; and, provided, further, that so long as this Note is registered in the name of DTC or its nominee, principal and interest payments will be paid to DTC or its nominee, as the
Holder, by wire transfer in same-day funds. 
  
 Reference is
hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 
  
 Unless the certificate of authentication hereon has been executed by the Trustee by manual signature of one of its
authorized signatories, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
  
 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal this 27th day of April, 2005. 
  

			
	 Health Care Property Investors, Inc.,

	 a Maryland corporation

		
	 By:
	 	 /s/ Talya Nevo-Hacohen

	 Name:
	 	 Talya Nevo-Hacohen

	 Title:
	 	 Senior Vice President—Strategic

	 	 	 Development and Treasurer

  
 Attest: 
  

			
	 By:
	 	 /s/ Edward J. Henning

	 Name:
	 	 Edward J. Henning

	 Title:
	 	 Senior Vice President, General Counsel

	 	 	 and Corporate Secretary

  

 2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION: 
  
 This is one of the Securities of the series designated herein referred to in the within-mentioned Indenture. 
  
 The Bank of New York, as Trustee 
  

			
	 By:
	 	 /s/ Authorized Signatory

	 	 	Authorized Signatory
		
	 Dated:
	 	  

  
 This Note is one of a
duly authorized issue of securities of the Company (herein called the “Notes”), issued as a series of securities under an indenture dated as of September 1, 1993 (the “Indenture”), between the Company and The Bank of New York, as
trustee (the “Trustee,” which term includes any successor trustee under the Indenture with respect to the Notes), to which Indenture and all indentures supplemental thereto, reference is hereby made for a statement of the respective
rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be, authenticated and delivered. This Note is the duly authorized series
designated as the “5 5/8% Senior Notes Due May 1, 2017,” originally limited (subject to exceptions
provided in the Indenture) in aggregate principal amount to $250,000,000; however, from time to time, without giving notice or seeking consent of the holders of the Notes, the Company may issue additional Notes of this series having the same
ranking, interest rate and maturity and other terms as the Notes. All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. 
  
 If an Event of Default with respect to the Notes shall occur and be
continuing, the principal of the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
  
 The Notes are not subject to redemption, in whole or in part, at the option of the Company and the Notes are not subject to any sinking fund. 

 
 As provided in and subject to the provisions of the Indenture, the Holder
of this Note shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written
notice of a continuing Event of Default with respect to the Notes, the Holders of not less than 25% in principal amount of the Notes at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such
Event of Default as Trustee and offered the Trustee reasonable indemnity and the Trustee shall not have received from the Holders of a majority in principal amount of the Notes at the time Outstanding a direction inconsistent with such request, and
shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of
principal hereof or any interest on or after the respective due dates expressed herein. 
  

 3 

 The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the
modification of the rights and obligations of the Company and the rights of the Holders of the Notes under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in aggregate principal
amount of the Outstanding Notes. The Indenture also contains provisions permitting the Holders of not less than a majority in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive compliance by the
Company with certain provisions of the Indenture. Furthermore, provisions in the Indenture permit the Holders of not less than a majority of the aggregate principal amount of the Outstanding Notes to waive, in certain circumstances, on behalf of all
Holders of the Notes, certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note
issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 
  
 No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation
of the Company, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the times, places and rate, and in the coin or currency, herein and in the Indenture prescribed. 
  
 As provided in the Indenture and subject to certain limitations set forth
therein, the transfer of this Note may be registered on the Security Register upon surrender of this Note for registration of transfer at the office or agency of the Company maintained for the purpose in any place where the principal of and interest
on this Note are payable, duly endorsed by or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by the Holder hereof or by his attorney duly authorized in writing, and
thereupon one or more new Notes of this series, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
  
 This Note may be transferred, in whole but not in part, only to a nominee of DTC, or by a nominee of DTC to DTC, or to a
successor to DTC for such Global Security selected or approved by the Company or to a nominee of such successor to DTC. If at any time DTC notifies the Company that it is unwilling or unable to continue as depositary for the Notes or if at any time
DTC ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, if so required by applicable law or regulation, the Company shall appoint a successor depositary with respect to the Notes. If (a) a successor
depositary for the Notes is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such unwillingness, inability or ineligibility, (b) an Event of Default has occurred and is continuing and the
beneficial owners representing a majority in principal amount of the Notes advise DTC to cease acting as depositary for such Notes, or (c) the Company, in its sole discretion, determines at any time that all Notes (but not less than all) of this
series shall no longer be represented by such Global Note or Notes, then the Company shall execute, and the Trustee shall authenticate and deliver, definitive Notes of like series, rank, tenor and terms in definitive form in an aggregate principal
amount equal to the principal amount of such Note or Notes. 
  

 4 

 The Notes are issuable only in registered form without coupons and may be sold in denominations of $1,000
and any integral multiple thereof. As provided in the Indenture and subject to certain limitations therein set forth, the Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series in authorized denominations
as requested by the Holders surrendering the same. No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in
connection therewith. 
  
 Prior to due presentment of the Note for
registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the
Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
  
 The Indenture contains provisions whereby (i) the Indenture shall cease to be of further effect with respect to the Notes (subject to the survival of certain provisions thereof), (ii) the Company may be discharged
from its obligations with respect to the Notes (subject to certain exceptions), or (iii) the Company may be released from its obligations under specified covenants and agreements in the Indenture, in each case if the Company satisfies certain
conditions provided in the Indenture. 
  
 No recourse shall be had
for the payment of the principal of or interest on this Note, or for any claim based hereon, or otherwise in respect hereof, or based on or in respect of the Indenture or any indenture supplemental thereto, against any past, present or future
stockholder, employee, officer or director, as such, of the Company or of any successor, either directly or through the Company or any successor, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment
or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue hereof, expressly waived and released. 
  
 THE INDENTURE AND THE NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF CALIFORNIA, AND FOR ALL
PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. 
  
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made
as to the correctness or accuracy of such CUSIP numbers as printed on the Notes, and reliance may be placed only on the other identification numbers printed hereon. 
  
 All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture.

  

 5 

 ASSIGNMENT FORM 
 FOR VALUE RECEIVED, THE UNDERSIGNED HEREBY 
 SELLS, ASSIGNS AND TRANSFERS TO 
  
 PLEASE INSERT SOCIAL 
 SECURITY OR OTHER IDENTIFYING 
 NUMBER OF ASSIGNEE 
  

  
  

 (Please Print or Typewrite Name and Address 
 including Zip Code of Assignee) 
  
  

  
 the within
Note of
                                        
and
                                        
hereby does irrevocably constitute and appoint 
  
  

 Attorney to transfer said Note on the books of the within-named Company with full power of substitution in the premises. 
  

					
	Dated:	 	  

	 	  

	 	 	 	 	  

  
 NOTICE: The signature to this
assignment must correspond with the name as it appears on the first page of the within Note in every particular, without alteration or enlargement or any change whatever. 
  

 6Officers' Certificate pursuant to Section 301 of the Indenture

 Exhibit 4.2 
  

HEALTH CARE PROPERTY INVESTORS, INC. 
  
 Officers’ Certificate 
  
 Mark Wallace and Edward J. Henning do hereby certify that we are the duly elected Senior Vice President and Chief Financial Officer, and Senior Vice
President, General Counsel and Corporate Secretary, respectively, of Health Care Property Investors, Inc., a Maryland corporation (the “Company”). We further certify that, pursuant to resolutions of the Board of Directors of the Company,
duly adopted by unanimous written consents dated December 10, 2003 and April 18, 2005 and attached hereto as Exhibit A, a series of Securities of the Company shall be established pursuant to Section 301 of the Indenture dated as of September
1, 1993 (the “Indenture”) between the Company and The Bank of New York, as Trustee, and that said series shall have the following terms and provisions: 
  
 (i) the title of such series of Securities shall be 5 5/8% Senior Notes due May 1, 2017 (referred to herein as the “Notes”); 
  
 (ii) the Notes which may be authenticated and delivered under the Indenture shall be limited to $250,000,000
aggregate principal amount (except as otherwise provided in Sections 304, 306, 906 or 1107 of the Indenture); however, from time to time, without giving notice or seeking consent of holders of the Notes, the Company may issue additional notes having
the same ranking, interest rate, and maturity and other terms as the Notes; 
  
 (iii) the Notes shall be issued as Registered Securities only, without coupons, and beneficial interests in the Notes may be acquired or subsequently transferred, only in denominations of $1,000 or in any amount in
excess thereof which is an integral multiple or $1,000; 
  
 (iv) the Notes shall be issued in the form of a permanent global certificate dated April 27, 2005; 
  
 (v) the principal amount of the Notes shall be payable on May 1, 2017; 
  
 (vi) interest on the Notes shall accrue at a fixed rate of interest as more fully described in the attached
form of Notes; the Notes will bear interest from April 27, 2005 and such interest will be payable semi-annually on May 1 and November 1 of each year (or, if such date is not a Business Day, on the next Business Day thereafter), commencing on
November 1, 2005 (each, an “Interest Payment Date”); the Regular Record Dates with respect to the Notes shall be each April 15 and October 15, respectively, whether or not a Business Day, preceding the relevant Interest Payment Date;
interest on the Notes will be calculated on the basis of a 360-day year of twelve 30-day months; 
  
 (vii) principal and interest payable with respect to the Notes shall be payable at the Corporate Trust Office of The Bank of New York,
located at 101 Barclay Street, Floor 8W, New York, New York 10286; 
  

 1 

 (viii) the Notes are not subject to redemption, in whole or in part, at the option of the
Company and the Notes are not subject to any sinking fund; and 
  
 (ix) the notes shall be issued in the form of one Book-Entry Security, and the Depository for such Notes shall be The Depository Trust Company or its nominee, and the beneficial owners of interests in such Book-Entry
Security may not exchange any such interests (except as provided by Section 305 of the Indenture). 
  
 We further certify, having read the Indenture, including Sections 303 and 501 thereof, and the definitions in the Indenture relating thereto and certain
other corporate documents and records, having made such examination or investigation as we deemed necessary to enable us to express an informed opinion, that all conditions precedent to the authentication and delivery of the Notes have been complied
with and, to the best of our knowledge, no event which is, or after notice or lapse of time would become, an Event of Default with respect to any of the Securities has occurred and is continuing. 
  
 Capitalized terms used herein that are not otherwise defined shall have the
meanings ascribed thereto in the Indenture. 
  

 2 

 IN WITNESS WHEREOF, the undersigned have executed this Officers’ Certificate as of the
22nd day of April, 2005. 
  

	
	 /s/    Mark Wallace

	Mark Wallace
	Senior Vice President and
	Chief Financial Officer
	
	 /s/    Edward J. Henning

	Edward J. Henning
	Senior Vice President,
	General Counsel and Corporate Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]